Teladoc Health, Inc. (4LL.F)
EUR 6.48
(1.54%)
EUR 6.48
(1.54%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.39 Billion USD | 1.08% |
| 2022 | 4.34 Billion USD | -75.5% |
| 2021 | 17.73 Billion USD | -0.12% |
| 2020 | 17.75 Billion USD | 1007.75% |
| 2019 | 1.6 Billion USD | 4.84% |
| 2018 | 1.52 Billion USD | 85.46% |
| 2017 | 824.39 Million USD | 171.48% |
| 2016 | 303.67 Million USD | 32.18% |
| 2015 | 229.73 Million USD | 149.7% |
| 2014 | 92 Million USD | 235.96% |
| 2013 | 27.38 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.32 Billion USD | -1.63% |
| 2024 Q2 | 3.52 Billion USD | -18.45% |
| 2023 Q4 | 4.39 Billion USD | 1.49% |
| 2023 Q2 | 4.31 Billion USD | 0.17% |
| 2023 Q3 | 4.32 Billion USD | 0.27% |
| 2023 FY | 4.39 Billion USD | 1.08% |
| 2023 Q1 | 4.3 Billion USD | -0.83% |
| 2022 FY | 4.34 Billion USD | -75.5% |
| 2022 Q4 | 4.34 Billion USD | -46.38% |
| 2022 Q3 | 8.1 Billion USD | 0.01% |
| 2022 Q2 | 8.1 Billion USD | -26.95% |
| 2022 Q1 | 11.09 Billion USD | -37.45% |
| 2021 Q2 | 17.61 Billion USD | 0.16% |
| 2021 FY | 17.73 Billion USD | -0.12% |
| 2021 Q3 | 17.65 Billion USD | 0.24% |
| 2021 Q4 | 17.73 Billion USD | 0.46% |
| 2021 Q1 | 17.58 Billion USD | -0.97% |
| 2020 FY | 17.75 Billion USD | 1007.75% |
| 2020 Q2 | 2.41 Billion USD | 50.89% |
| 2020 Q3 | 3.44 Billion USD | 42.61% |
| 2020 Q1 | 1.6 Billion USD | 0.02% |
| 2020 Q4 | 17.75 Billion USD | 414.74% |
| 2019 Q2 | 1.56 Billion USD | 0.88% |
| 2019 FY | 1.6 Billion USD | 4.84% |
| 2019 Q3 | 1.56 Billion USD | 0.2% |
| 2019 Q4 | 1.6 Billion USD | 2.19% |
| 2019 Q1 | 1.55 Billion USD | 1.49% |
| 2018 Q3 | 1.53 Billion USD | 27.94% |
| 2018 Q4 | 1.52 Billion USD | -0.41% |
| 2018 Q1 | 817.52 Million USD | -0.83% |
| 2018 Q2 | 1.19 Billion USD | 46.77% |
| 2018 FY | 1.52 Billion USD | 85.46% |
| 2017 Q4 | 824.39 Million USD | -6.42% |
| 2017 Q3 | 880.92 Million USD | 30.67% |
| 2017 FY | 824.39 Million USD | 171.48% |
| 2017 Q1 | 413.95 Million USD | 36.32% |
| 2017 Q2 | 674.14 Million USD | 62.86% |
| 2016 Q3 | 313.26 Million USD | 53.65% |
| 2016 Q4 | 303.67 Million USD | -3.06% |
| 2016 Q2 | 203.89 Million USD | -4.49% |
| 2016 Q1 | 213.48 Million USD | -7.08% |
| 2016 FY | 303.67 Million USD | 32.18% |
| 2015 Q1 | 87.36 Million USD | -5.05% |
| 2015 Q3 | 243.28 Million USD | 127.49% |
| 2015 Q2 | 106.94 Million USD | 22.41% |
| 2015 Q4 | 229.73 Million USD | -5.57% |
| 2015 FY | 229.73 Million USD | 149.7% |
| 2014 Q4 | 92 Million USD | 0.0% |
| 2014 FY | 92 Million USD | 235.96% |
| 2013 FY | 27.38 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| DocCheck AG | 59.1 Million EUR | -7331.092% |
| CompuGroup Medical SE & Co. KGaA | 1.89 Billion EUR | -131.184% |
| MeVis Medical Solutions AG | 28.05 Million EUR | -15556.867% |
| Nexus AG | 411.71 Million EUR | -966.844% |